Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice

World Journal of Gastroenterology

Volumn 6, Issue 2, 2000, Pages 210-215

  Yuan, Jin Hui ^a,c,d   Zhang, Ru Ping ^a   Zhang, Ru Gang ^a   Guo, Li Xia ^a   Wang, Xing Wang ^a   Luo, Dan ^b   Xie, Yong ^b   Xie, Hong ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c Henan Luoyang Medical School   (China)

^d ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PACLITAXEL; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; FEMALE; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER TUMOR; MICROSCOPY; MITOSIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; TUMOR GROWTH;

EID: 0034002587     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Wani MC, Taylor HL, Wall ME, Coggon P, Mcphail AT. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc, 1971;93:2325-2327
2. Douros J, Suffness M. New natural products of interest under development at the National Cancer Institute. Cancer Chemother Pharmacol, 1978;1:91-100
3. Riondel J, Jacrot M, Picot F, Beriel H, Mouriquand C, Potier P. Therapeutic response to taxol of six human tumors xenografted into nude mice. Cancer Chemother Pharmacol, 1986;17:137-142
4. Riondel J, Jacrot M, Nissou MF, Picot F, Beriel H, Mouriquand C, Potier P. Antineoplastic activity of two taxol derivatives on an ovarian tumor xenografted into nude mice. Anticancer Res, 1988;8:387-390
5. Rowinsky EK, Donehower RC. Taxol: Twenty years later, the story unfolds. J Natl Cancer Inst, 1991;83:1778-1781
6. Rowinsky EK, Donehower RC. Paclitaxel. N Engl J Med, 1995;332:1004-1014
7. Sandercock J, Parmar MK, Torri V. First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence. Br J Cancer, 1998;78:1471-1478
8. Ferrante K, Winograd B, Canetta R. Promising new developments in cancer chemotherapy. Cancer Chemother Pharmacol, 1999;43(Suppl):S61-68
9. Lui WY, Chang YF, Li LL, Ho LK, Su TL, Chen JY, Liu TY, P'Eng FK, Chi CW. Differential paclitaxel-induced cytotoxicity in rodent and human hepatoma cell lines. Anticancer Res, 1998;18:3339-3345
10. Gagandeep S, Novikoff PM, Ott M, Gupta S. Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines. Cancer Lett, 1999;136:109-118
11. Milross CG, Mason KA, Hunter NR, Chung WK, Peters LJ, Milas L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst, 1996;88: 1308-1314
12. Strumberg D, Erhard J, Harstrick A, Klaassen U, Muller C, Eberhardt W, Wilke H, Seeber S. Phase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinoma. Eur J Cancer, 1998;34:1290-1292
13. Chao Y, Chan WK, Birkhofer MJ, Hu OY, Wang SS, Huang YS, Liu M, Whang-Peng J, Chi KH, Lui WY, Lee SD. Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer, 1998;78:34-39
14. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B. The biochemistry of programmed cell death. FASEB J, 1995;9:1277-1287
15. Solary E, Bertrand R, Pommier Y. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. Leuk Lymphoma, 1994;15:21-32
16. Torres K, Horwitz SB. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res, 1998;58: 3620-3626
17. cdc2 kinase. Mol Cell, 1998;2:581-591
18. Yuan JH, Wang XW, Luo D, Xie Y, Xie H. Anti-hepatoma activity of Taxol: an in vitro study. Zhongguo Yaoli Xuebao, 2000;21:in press
19. Richardson DR, Mines K. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone. Blood, 1997;89: 3025-3038
20. Bullard DE, Schold SC Jr, Bigner SH, Bigner DD. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J Neuropathol Exp Neural, 1981;40:410-427
21. 2/M cell cycle arrest. Br J Cancer, 1998;77:404-411
22. 1-dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol. Int J Cancer, 1998;75:925-932